Not yet registered on PMX
This profile is generated from public regulatory records. The company has not registered on PMX yet, and PMX has not verified it.
- Country
- Pakistan
- Region
- Asia
Regulatory licences
- DMLName on licence: Citi pharma ltd
Registered products
51 products
Citi Chew 500mg tabletAscorbic Acid 500mg (USP Specification)500mgCitiquin 200mg tabletHydroxychloroquine Sulfate 200mg (USP Specification)200mgDuetec 150mg tabletRanitidine HCl equivalent to Ranitidine 150mg(USP Specification)150mgDuetec 3000mg tabletRanitidine HCl equivalent to Ranitidine 300mg(USP Specification)300mgEscitram Tablets 10mgEscitram as Oxalate 200mg(USP Specification)200mgFloxcip 250mg TabletCiprofloxacin HCl equivalent to Ciprofloxacin 250mg(USP Specification)250mgFloxcip Tablet 500mgCiprofloxacin HCl equivalent to Ciprofloxacin 500mg(USP Specification)500mgFlucogals 150mg CapsulesFluconazole 150mg (BP Specification)150mgFlucogals 2000mg CapsulesFluconazole 200mg (BP Specification)200mgFlucogals 50mg CapsulesFluconazole 50mg (BP Specification)50mgFlucogals Dry Powder SuspensionFluconazole 50mg (USP Specification) (per 5ml)50mg/5mlKalos 120mg/5ml suspensionIbuprofen 100mg(USP Specification) (per 5ml)100mg/5ml